Washington Trust’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Washington Trust's IBB Position: Q2 2025 in Review
Washington Trust sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 400 shares — an estimated $51.2K sold.
Washington Trust first reported a position in IBB in Q2 2018 and held it in 22 quarters. The position peaked at $81K in Q4 2023. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.
- Washington Trust reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
- Washington Trust sold 400 iShares Biotechnology ETF shares in Q2 2025, an estimated $51.2K.
- Washington Trust first reported a position in iShares Biotechnology ETF in Q2 2018 and held it in 22 quarters.
- Washington Trust's iShares Biotechnology ETF position peaked at $81K in Q4 2023.
- 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.
Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.